Podcasts about Nomenclature

Send us a textAfter much anticipation since we started this podcast, Stuart Colburn joins us for a special episode focused on Texas! Stuart, a shareholder at Downs & Stanford, P.C., has over 25 years of experience in workers' compensation. He shares his journey into our industry and expertly navigates the evolution of the Texas Workers' Compensation system since the 1980s. Throughout the conversation, he highlights the unique aspects that make Texas' approach distinctly different from those of other states.Stuart is board certified in Workers' Compensation Law by the Texas Board of Legal Specialization and was the founder and first Chair of the State Bar of Texas Workers' Compensation Section. He co-authors the Texas Workers' Compensation Handbook published by LexisNexis and, as a certified lobbyist and frequent Division of Workers' Compensation conference representative, brings valuable policy perspective to the conversation.(Correction: Stuart mentions 2011 as the year Wikipedia and iTunes emerged; however, the correct year is 2001.)NOTE: Stuart shares a slide deck during this episode, which you can see in the video version on our YouTube channel. Resources mentioned in this episode:Texas Workers' Compensation Handbook 2025 EditionTexas Department of Insurance - Workers' Compensation Texas Subsequent Injury FundAmerican Medical Association (AMA) GuidesOfficial Disability Guidelines ODG by MCG National Comp ConferenceStuart Colburn bio¡Muchas Gracias! Thank you for listening. We would appreciate you sharing our podcast with your friends on social media. Find Yvonne and Rafael on Linked In or follow us on Twitter @deconstructcomp

Dr. Adam Striker discusses PECS blocks and nomenclature with Dr. Christine Vo, member of the ACE editorial board. Learn about the history and efficacy of PECS blocks, the challenges of heterogeneous nomenclature, ongoing efforts to standardize nomenclature, and more. Recorded April 2025.

Talking all about multi-aspect heroes! In this episode, Boomguy and AndyR explore the theme of multi-aspect heroes in Marvel Champions, discussing various deck archetypes and showcasing specific decks centered around characters like Adam Warlock, Spider-Woman, Cable, Gamora, and Cyclops. They delve into listener comments, the dynamics of different player archetypes, and the unique challenges and strategies involved in building multi-aspect decks. We highlight the creativity and fun that can arise from these unique deck-building opportunities while also acknowledging the complexities they introduce. 1. Children of the Atom (Warlock): https://marvelcdb.com/decklist/view/44735/children-of-the-atom-warlock-1.0 2. Jess & Carol Kill the Marvel Universe: https://marvelcdb.com/decklist/view/39819/jess-and-carol-kill-the-marvel-universe-1.0 3. Maria Maria (Do your friends love cards?): https://marvelcdb.com/decklist/view/45479/maria-maria-do-your-friends-love-cards-1.0 4. Psy-Kickin' It: https://marvelcdb.com/decklist/view/44648/psy-kickin-it-1.0 5. Rogue+Pete=8+ Gunboat every time!: https://marvelcdb.com/decklist/view/44997/rogue-pete-8-gunboat-every-time-1.0 6. What if we used 100% of Gamora's ability? [True Solo]: https://marvelcdb.com/decklist/view/45030/what-if-we-used-100-of-gamora-s-ability-true-solo-1.0 Chapters 00:00 Introduction to Winning Hand and Deck Building 01:07 Understanding Spike, Johnny, and Timmy Players 04:19 The Timmy Player Dilemma in Marvel Champions 09:06 Nomenclature for Deck Archetypes 13:10 Exploring Multi-Aspect Heroes 17:43 Deck Showcase: Adam Warlock 23:46 Deck Showcase: Spider-Woman 29:29 Deck Showcase: Cable 32:13 Exploring Psionic Strategies 34:46 Deck Building Insights and Recommendations 37:02 Maria Hill: The Card Draw Engine 39:58 Gamora's Solo Deck: A Unique Approach 50:34 Cyclops and Gunboat Diplomacy 01:02:52 Reflections on Multi-Aspect Heroes

Corbin Fraser is the new CEO of Bitcoin.com. In this episode, he talks about the Scaling Wars, his perspective as a BCH advocate, and the lessons the market taught him over the years. Also, he explains why the news section of Bitcoin.com improved. Introducing Corbin Fraser (00:00:50) Bitcoin.com's Evolution (00:01:52) Support for Multiple Cryptocurrencies (00:03:05) Challenges of Tribalism in Crypto (00:06:51) Origins of Bitcoin Cash (00:09:07) The Scaling Wars (00:12:14) Misconceptions About BCH Leadership (00:15:23) The Meme Warfare (00:18:31) Promoting Token Swaps (00:20:09) Bitcoin.com News and Geopolitics (00:21:16) Respect for Peter Schiff (00:22:01) Occupy Wall Street Insights (00:22:12) Bitcoin Cash vs Bitcoin Debate (00:24:25) Vitalik's Perspective on Forks (00:25:04) Nomenclature and Propaganda (00:26:17) Cola Wars Analogy (00:28:31) Future of Bitcoin Block Size (00:29:56) Lightning Network Adoption Challenges (00:30:04) Alternative Layer 2 Solutions (00:31:27) Lightning Network's Technical Limits (00:32:33) Bitcoin SV and Centralization Concerns (00:33:42) Impact of Community Divisions (00:34:44) Chaos of Forks in 2017 (00:36:58) Bitcoin.com's Business Approach (00:40:04) Lightning Network Whitepaper Block Size (00:41:06) Discussion on AI and Block Size (00:42:39) Satoshi's Misjudgments (00:43:46) Censorship and Community Chaos (00:45:34) Personal Losses During the Block Size Wars (00:47:08) Bitcoin Cash's Price Surge to $3000 (00:47:38) Miner Hesitation (00:48:30) Current Features of BCH (00:51:55) Emergence of Cash Tokens & Failure of SLP (00:56:02) Building on UTXO (01:00:18) Ethereum's Rise Post-Scaling Wars (01:02:10) SushiSwap & DeFi Summer (01:03:53) Vampire Liquidity Attack (01:05:08) Speculation Around Chef Nomi (01:06:27) Development of Aave & Compound (01:07:30) Community Dynamics in BCH (01:08:32) Debate on Development Tax (01:09:43) Amaury Sechet's Influence and Community Split (01:10:14) Forking and Community Fragmentation (01:12:12) Transition to Ethereum and DeFi (01:14:39) The Role of Multi-Chain Strategies (01:19:12) Privacy and Zano (01:20:41) Operational Security and Privacy in Crypto (01:23:09) Government Regulation and Crypto Development (01:24:31) Zano's Hybrid PoW/PoS Consensus (01:25:56) Fact-Checking from Bitcoin Cash Podcast (01:27:13) Bitcoin Cash Upgrade Schedule (01:28:14) Twitter Spaces Collaboration (01:28:47) Privacy Solutions in BCH (01:29:29) Mike Hearn's Prediction on Forks (01:30:05) Misleading Media Influence (01:30:57) Dollar Cost Averaging Strategy (01:31:50) Self-Custody Solutions (01:32:02) Ownership of Bitcoin.com (01:33:54) Roger Ver's Contributions (01:34:22) Support for Roger Ver (01:36:25) Government's Stance on Crypto (01:38:47) Reading Roger's Defense (01:39:59) Misinterpretations of Roger's Position (01:41:08) Evolution of Roger Ver's Views (01:42:31) Market Humbling Experiences (01:42:54) Elon Musk's Influence (01:43:37) Current Crypto Market Sentiment (01:45:01) Celebrity Influence on Crypto (01:46:05) Kanye West's Coin Speculation (01:47:01) Kanye's Meme Coin Ventures (01:48:05) The Decline of Meme Coin Interest (01:49:16) Overvaluation in Crypto Projects (01:50:50) Block Size Wars Reflection (01:51:48) State Actors and Bitcoin's Challenges (01:52:51) Blockstream's Business Struggles (01:54:41) Developer Commitment and Innovation (01:56:34) Stablecoins vs. Bitcoin Adoption (02:00:05) Future of Stablecoins and CBDCs (02:01:33) Block Size Debate and Social Consensus (02:04:08) George Hotz's Perspective on Innovation (02:06:48) Ethereum's Rapid Development (02:09:07) Ethereum's Challenges (02:11:29) Bitcoin's Cautious Approach (02:12:05) Testing Protocols (02:13:15) User Education on Risks (02:15:35) Brock Pierce's Influence (02:16:21) Community Engagement (02:18:17) Listing Criteria for New Coin on Bitcoin dot com Wallet (02:20:34) Integration of Privacy Coins (02:22:58) Zano's Potential (02:24:01) User Confusion with Bitcoin Domains (02:28:21) BSV Integration Decision (02:30:36) Balanced News Coverage (02:32:04) Introduction to New Developments (02:33:07) Embracing a Broader Crypto Perspective (02:34:05) Closing Remarks (02:34:46) Final Thoughts and Future Plans (02:35:03)

Deep Chandh Raja, MBBS, MD, PhD, Australian National University, Kauvery Hospital, is joined by Dhiraj Gupta, MBBS, MD, Liverpool Heart and Chest Hospital, and Dominik K Linz, MD, PhD, Maastricht University Medical Center, to discuss a international position paper, developed by the Working Group of the Signal Summit, highlights the challenges in understanding and treating atrial fibrillation (AF), the most common arrhythmia in adults. Despite technological advancements in pulmonary vein isolation (PVI), progress in understanding AF mechanisms, structural changes, and phenotypic differences has been limited due to inconsistent terminology, suboptimal mapping techniques, and the complex nature of AF itself. The paper aims to establish clearer definitions, promote standardized approaches, and propose research pathways to improve AF therapies and patient outcomes.  https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(24)03564-1/fulltext Host Disclosure(s): D. Raja: Nothing to disclose.   Contributor Disclosure(s): D. LInz: Nothing to disclose. D. Gupta: Research: Medtronic Bakken Research Center, Biosense Webster, Inc., Boston Scientific   This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365: https://www.heartrhythm365.org/URL/TheLeadEpisode94

The FDA has released its draft guidance for industry on the labeling of plant-based alternatives to animal-derived foods. The comment period is open until March.

Merriam-Webster's Word of the Day for January 25, 2025 is: nomenclature • NOH-mun-klay-cher • noun Nomenclature is a formal word that refers to a system of names that is used in specialized fields and especially in science. Nomenclature is also used more broadly as a synonym of name and designation. // It took Faith, a trained herpetologist, a while to become familiar with the nomenclature used at the entomology conference. See the entry > Examples: “The junior leagues wanted to instill the same type of nomenclature and methods used at the high school varsity level and teach the same type of philosophies.” — Rodger Roeser, Cleveland.com, 25 Nov. 2024 Did you know? Nomenclature has everything to do with names: it can refer to the act of naming, a name itself, and even a system of names—you name it! The term comes to English from the Latin word nōmenclātūra, which means “assigning of names to things.” One may marvel, for instance, at the nomenclature—that is, names—of towns in the United States, from Ninety-Six (South Carolina) to Frankenstein (Missouri). Or one may be required to learn the nomenclature—the system of naming—of a particular branch of science. If nomenclature reminds you of a term you heard in biology class, you know what we mean. Binomial nomenclature refers to a system of nomenclature in which each species of animal or plant receives a name of two terms, of which the first identifies the genus to which it belongs and the second the species itself. For example, the scientific name for humans according to this nomenclature is Homo sapiens.

This episode of RAPM Focus introduces something new—an episode generated completely by artificial intelligence, specifically Google Notebook. As part of RAPM's commitment to exploring innovative ways to deliver content, RAPM is trialing this approach and would love to hear your feedback. This AI-generated episode is centered around an original research paper first published in RAPM in November 2024, “Standardizing nomenclature in regional anesthesia: an ASRA-ESRA Delphi consensus study of upper and lower limb nerve blocks.” This podcast episode highlights the power of clear communication in medicine, and the ways in which nomenclature brings order to the world of medical terminology. Specifically, the inconsistent naming of nerve blocks can lead to confusion and chaos that result in real consequences. Different doctors and researchers using different names for the same techniques leads to difficulties in comparing results and sharing knowledge. “Standardizing nomenclature in regional anesthesia: an ASRA-ESRA Delphi consensus study of upper and lower limb nerve blocks” dives into how convoluted the names of nerve blocks have become. This leads to a recipe for miscommunication—not ideal in the world of pain management. By standardizing the nomenclature of nerve blocks, patient safety is increased for those undergoing surgeries involving nerve blocks. The study lays out a clear system for naming nerve blocks in order to standardize the language of nerve blocks. This system showcases the importance of nomenclature in not just nerve blocks, but in pain management and medicine as a whole. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a health care practitioner's judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Find RAPM on X @RAPMOnline, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.

On the fourth (Toruk-sized) episode of The Avatar Podcast, Albert takes one last look at 2024, shares some hidden or overlooked ‘Fire and Ash' teases from some recent interviews, and much more (including Avatar: The Musical)! We end the episode as we do each week with the Weekly Showcase and Member Mailbag. Enjoy, my friends (Txasunu, ma 'eylan)!Chapters 00:00:00 Start (Who Is ‘Pandorapedia Person'?)00:00:35 Welcome! (Segment Overviews)00:01:00 Preview of upcoming segments00:02:50 Mailbag announcement00:03:19 Segment 1 - Avatar's 2024 (Recap)00:04:50 Jim's Disney Legend Ceremony00:15:25 Segment wrap-up (Pinar's nomination)00:15:52 Gratitude for the community00:17:20 Segment 2 - The Interviews00:17:50 Interview 1 - Writing Avatar00:19:30 ‘Auditioning' writers00:20:30 Silver and Jaffa (A2/A3)'s adventure00:21:25 Shane (A5) talks working with Jim00:23:35 Josh (A4) talks working with Jim 00:27:00 The ‘bullshitting around' bylaw00:28:25 Shane describes the art department00:29:30 The ‘uncollapsed superposition'00:31:24 Shane clarifies who wrote which film00:32:10 Breaking A2's first act00:35:45 Jim talks about The High Ground00:37:35 We've only seen Avatar 1.500:43:00 Gen Z in Avatar00:45:30 Expensive Indie Movies00:51:00 Pandorapedia Person Revealed (Dani)00:55:00 Silver: It takes guts to not be cynical 01:00:40 Jim: ‘I cannot f-ing wait'01:01:53 Interview 2 - French Interview01:04:10 Jim's Bioluminescent Dream01:04:55 The metaphor of Humans/Na'vi01:06:22 ‘We shouldn't feel defeated'01:13:10 ‘We have a lot of fun'01:15:45 Interview 3 - Edith Bowman01:22:30 Music in the Sequels01:25:00 'Songcord' Origins01:29:55 How P-Cap is less artificial01:33:40 Music in Avatar: Fire and Ash01:34:20 The Avatar Troupe01:37:20 A3 is in the can/bringing Lo'ak forward01:39:20 Kiri comes into her own in A301:44:00 ‘More goddess energy'01:45:15 Interview 4 - Editing Avatar01:48:10 Proxy scenes01:49:20 Kevin 's versatility01:51:40 Jim's directing01:56:50 Weta's shot maturation02:03:50 shots as springboards for ideas02:05:05 The Infinite Choice Problem02:13:00 What Jim sees (viewfinder)02:17:10 Nobody is keyframe animated02:18:10 How complex P-cap gets02:19:10 Roxto pronunciation02:28:25 Editing ‘Fire and Ash'02:30:12 Interview 5 - Q&A with Jim and Jon02:34:10 Fox's reaction to A302:37:10 Ilu and Skimwing differences02:40:35 ‘no pre-viz, just viz'02:43:45 Avatar's narrow band of expression02:48:30 Filming Spider02:56:10 ‘A Window into a World'03:00:10 What A2 survived03:03:15 ‘Cinemas are dying' since 198303:05:15 ‘Cinemas are dying' since 196303:06:32 Ponzi streaming03:09:10 Segment 3 - 8 Artforms, 8 Ideas03:11:35 Avatar's Meta Headset Experiences03:12:50 Eywa's Amplified Involvement03:16:05 Segment 4 - Daily Avatarisms + NYE03:17:55 Nomenclature speculation: Na'vi03:19:00 Honouring natural growth (self)03:20:00 Echo of Eywa: “Let's Get It Done”03:22:00 Segment 5 - Weekly Showcase03:22:10 Activist - Avelin Kambiwa03:24:05 Animal - Flying Fish03:25:35 Area - Upper Plains03:25:53 Artist - Nalei Nimun03:26:25 Cast - Kevin Dorman03:29:05 Cosplay - Michael Martel03:30:20 Craft - Ganjamira03:30:45 Crew - Ben Milsom03:32:05 Editor - JL Entertainment03:32:45 Fact - 10,000 Trees03:33:28 Fauna - Thanator (Palulukan)03:35:35 Flora - Warbonnet Fern03:35:45 Person - Upiter J03:36:25 Na'vi - So'lek03:37:55 Photo - Visions of Pandora (Ta'nari)03:39:10 Place - The Great Plains (Canada)03:40:10 Plant - Cycads03:40:30 Phrase - I See You03:41:10 RDA - Crab Suit03:41:35 Theorist - Avatar Theory (Basil)03:42:45 Tease - Bazooka Mangkwan03:41:50 Trivia - 2,600 Na'vi Words03:42:25 Wish - Avatar on the rise!03:43:00 Shout ot to Reddit03:43:10 Merch - Shoulder Banshee03:43:30 Culture - Alcheringa and TSI03:44:20 Thanks - Daphne Yap's Patterns03:44:55 Wrap Up03:45:10 Like, Share, Subscribe, Join, Ring the Bell, leave a review, and be well! Kiyevame!CreditsSee YouTube Version

This episode and blog explores the history of plants, where their names come from, and some overarching categories plant names are separated into. I know the naming and categories are ever changing but let's learn the basics together!! Remember to check out the corresponding blog post for this episode and visit my website www.houseplant-homebody.com/ for more details!  ---------------------------------- Don't forget to follow Houseplant Homebody on Instagram, Facebook, TikTok and Pinterest.  Please rate or review this podcast and share Houseplant Homebody with your friends! Odds are, if you like this podcast others will too! ---------------------------------- If you want EVEN MORE of Houseplant Homebody, become a Supporter, shop HH merch, sign up for the quarterly newsletter or reach out with a question, request or just say hi! I love hearing from each of you! Thank you SO much for listening!

Jon quizzes Heather and Jim to find out just how much they know about hunting

D'Weltklimakonferenz, déi haut zu Baku ufänkt, déi ugespaante Situatioun an der Gemeng Conter a Chaos op der Uni.lu wéinst enger neier Nomenclature, an där "of science" ewechfält, sinn Theemen an der Presserevue.

In today's episode, I talk all about how I injured my leg at my sister's wedding, the race riots currently happening in the UK, not so nice, and end with some motivation for all of you. Very nice. Keep listening to learn English! Go to EasyStoriesInEnglish.com/Wedding for the full transcript. Mit dem Code easystories erhältst du das 12-Monatsabo von Babbel zum Preis von nur 6 Monaten. Das Angebot gilt bis zum 31. Oktober 2024. Einfach auf https://www.babbel.com/audio einlösen und loslegen. Get episodes without adverts + bonus episodes at EasyStoriesInEnglish.com/Support. Your support is appreciated! Vocabulary: Buddy, Nomenclature, Yap, Gen Z, Segment, Ramble, Civil partnership, Registrar, Brother-in-law, Bonfire, Cartwheel, Pull a hamstring, Ceilidh, Gaelic, Calves, Killing me, Polyamorous, Sedate, Woo woo, Stoic, Two sides of the same coin, Adman, Conscript, Eyewitness, Testify, Tabloid newspaper, Beaver, Rewilding, Double whammy, Food for thought, Ultra-processed food, A rule of thumb, Livestock, Calf (cow), Fasting Learn more about your ad choices. Visit megaphone.fm/adchoices

Small, brown and confounding

Small, brown and confounding

取名字对每个迎接新生儿的家庭来说都是一件值得反复讨论的大事，中国人取名字除了反映父母的期望之外，还有哪些方方面面的讲究呢？赶快来了解一下。 Episode link: https://www.chinesepod.com/2928

Clue Perfumery Perfumer & Co-Founder Laura Oberwetter is in the Perfume Room this week! In 2021, Laura DMed me asking if I knew of any good perfumery resources. Cut to 2024; she's launched her own brand, created 4 scents, and has already been nominated for an IAO Award. Today we discuss how she did it, where she seeks inspiration, and the importance of cross-modal translation and intentionality in all of her creations. Plus, the best-smelling mascara. AND OF COURSE, we discuss the newest launch, The Point. SUBSCRIBE TO PERFUMEROOM.SUBSTACK.COM FOR A FULL REVIEW OF THE THE NEW JORUM STUDIO TIME COLLECTION AS WELL AS THE PERFUME ROOM POST-SHOW INTERVIEW WITH LAURA (COMING THIS FRI!) FRAGS MENTIONED: Jorum Studio Monolith, Diptyque Benjoin Boheme, Jorum Studio: Zhaar, Opaline; Clue Perfumery The Point, Pantene Pro-V Shampoo, Ed Hardy Villain, Juicy Viva La Juicy, D&G Light Blue, Dry Idea deodorant, Ilia mascara, t gel, Escentric Molecules, CdG, Nomenclature, Frederic Malle, Clue Perfumery Warm Bulb, CdG Black Pepper, Replica Beach Walk, Clue Perfumery: With a Candle Stick, Morel Map; Tea Tree Therapy SHOP: clueperfumery.com FOLLOW: @clueperfumery (IG) | @keyhole___gazer (TT)

Tonight we're talking about the LP trainwreck, renaming criminals, Signal being an op, are tacos sandwiches?, the Biden campaign hiring a meme manager, another Greater Idaho update, an Ohio bill banning "mass casualty' guns, Uvalde parents suing everyone, and whatever else we stumble into! https://linktr.ee/anarchyamongfriends https://www.youtube.com/watch?v=cfk5s-migxI Dyreka's Crochet Pattern - https://www.ravelry.com/patterns/library/hungry-caterpillar-educational-toy Dyreka's book - https://www.amazon.com/Think-Yourself-Critical-Thinking-Beginners/dp/1791936172/ref=sr_1_fkmrnull_1 Andrew's YT - https://www.youtube.com/channel/UCYuYw7aFnaJBc8F6NCn-CKg/videos "InkedAnarchist15" for 15% off at https://www.thebeardstruggle.com/?rfsn=4064657.9a3f66&utm_source=refersion&utm_medium=affiliate&utm_campaign=4064657.9a3f66 https://www.reaperapparelco.com/?ref=52cju0Cb Or use "InkedAnarchist" at checkout and get 10% off. RK Sppokware https://rkspookware.com?aff=11 Jeremy at The Quartering's 'Coffee Brand Coffee': https://coffeebrandcoffee.com/?ref=eryobzq3 Check out Road to Autonomy https://rtamagazine.com/ Poppins Patches - https://www.facebook.com/poppinspatches or poppinspatches.com Anarchy Among Friends Telegram - https://t.me/AAFRTD Anarchy Among Friends FB - https://www.facebook.com/AAFRTD Anarchy Among Friends Odysee - https://odysee.com/@AnarchyAmongFriendsRoundtableDiscussion:5 Anarchy Among Friends Rumble - https://rumble.com/user/Valhallarchist Spotify - https://open.spotify.com/show/0pqbeHBmWPN1sG0e6L28Uv Podbean - https://www.podbean.com/podcast-detail/8yy6n-c5c4e/Anarchy-Among-Friends-Podcast Apple Podcasts - https://podcasts.apple.com/us/podcast/anarchy-among-friends/id1459037636?ign-mpt=uo%3D4 Stitcher - https://www.stitcher.com/podcast/anchor-podcasts/anarchy-among-friends GooglePodcasts - https://podcasts.google.com/?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy9hNGZmNzQwL3BvZGNhc3QvcnNz Breaker - https://www.breaker.audio/anarchy-among-friends Overcast - https://overcast.fm/itunes1459037636/anarchy-among-friends PocketCasts - https://pca.st/CDH3 RadioPublic - https://radiopublic.com/anarchy-among-friends-Wkzzjl Brandenburg v. Ohio, 395 U.S. 444 (1969), was a landmark United States Supreme Court case, interpreting the First Amendment to the U.S. Constitution. The Court held that government cannot punish inflammatory speech unless that speech is "directed to inciting or producing imminent lawless action and is likely to incite or produce such action. https://en.wikipedia.org/wiki/Brandenburg_v._Ohio THIS PODCAST IS COVERED BY A BipCot NoGov LICENSE. USE AND RE-USE BY ANYONE EXCEPT GOVERNMENTS OR THEIR AGENTS IS OK. MORE INFO: https://bipcot.org/ Nomenclature - https://dailycaller.com/2024/05/22/illinois-lawmakers-criminals-justice-impacted-individuals-offenders/ Signal - https://dailycaller.com/2024/05/12/signal-app-open-technology-fund-government-agency-katherine-maher-national-public-radio/ Tacos - https://www.nbcwashington.com/news/national-international/indiana-judge-rules-tacos-and-burritos-are-mexican-style-sandwiches/3617342/ Meme - https://www.washingtontimes.com/news/2024/may/21/biden-campaign-to-hire-meme-manager-as-president-s/ Greater Idaho - https://www.msn.com/en-us/news/us/13-oregon-counties-have-now-joined-the-greater-idaho-movement/ar-BB1mS5Yt Ohio - https://www.wdtn.com/news/ohio/new-bill-seeks-to-limit-mass-casualty-guns-in-ohio/ Uvalde - https://www.yahoo.com/news/uvalde-victims-families-sue-meta-213350475.html

The guys open things up with some interesting discussion on biscuits, small wrestlers, and chicken. Hale McGranahan is in to offer his thoughts from the recruiting trail. He gets us up to speed with the latest offers, and takes a look at the upcoming camp season. They key in on some specific names, and what positions are still of need from the portal. Nyck Harbor comes up with some speculation on how the rest of his summer could look. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

My links: My patreon: ⁠https://www.patreon.com/user?u=103280827 My Ko-fi: https://ko-fi.com/rhetoricrevolution Send me a voice message!: https://podcasters.spotify.com/pod/show/liam-connerly TikTok: ⁠https://www.tiktok.com/@mrconnerly?is_from_webapp=1&sender_device=pc⁠ Email: ⁠rhetoricrevolution@gmail.com⁠ Instagram: https://www.instagram.com/connerlyliam/ Podcast | Latin in Layman's - A Rhetoric Revolution https://open.spotify.com/show/0EjiYFx1K4lwfykjf5jApM?si=b871da6367d74d92 Gut Guardian Discount Code: https://www.feelgoods.co/discount/LIAM64728

Latin Prefixes *Hook Word (mnemonic for memorization) A-, Ab-; away from Absent (word hook) Ad-; to, towards addition Ambi- (Ambo-, amb-, am-, an-); around, on both sides ambivalent Ante-; before, forward antebellum Antero-, anterior; before, front or forward part (Anterior) (see: antero-) Bi- (bis-, bin-); twice Bicycle Circum-; around circumference Contra- (Counter- often before vowels); against, opposite contraindicated  De-; down from, away deficient   Extra-, extro-; beyond, on the other side, outer (extrapulmonary, extraligamentous) external, extraordinary  Infra-; below, lower (Inferior, infraspinatus, infrascapular, infracostal) Inferior Inter-; between (intervascular, interosseous) interloper  Intra-; within, inside, during (intracervical) Intra-racism  Juxta-; beside (juxtarticular, juxtaspinal) Juxtaposition Ob- (o-, oc-, op-); against, in the way, facing (occiput) object, objective Post-; after, behind (Posterior, Postcerebral, postnatal) poster Postero-; behind (Posterior, posterolateral, posterosuperior) postscript Prae- (pre); before, in front of (precordium) preclude  Retro-; backward, behind (retroflexion, retronasal) retrograde Semi-; half (semiorbicular) semicircle Sub- (suc-, suf-, sup, sus-); under, below, near, somewhat (subdorsal, subcutis) submarine  Super- (sur-); over, above (Superior) superior Supra-; Above, upon (supra-axillary, supraspinatus, suprapelvic) (see: super-) Trans- (often tran- before ‘s'); across, through (Transverse, transverse Abdominous, tranverse plane) Transcript  Ultra-, ultro-; beyond, excessive (ultraligation, ultrasetaceous) ultra-runner, ultraviolet Greek Prefixes An, A-; not, without (anemia) absent Amphi-; around about (amphibian) amphibian Ana-, ano-; up, back, again (aneurysm) analysis Anti- (anth-); against, resisting antagonist Apo-; from, separation (apostasies: STA- “to stand”) apostle Arche-, archi-; first, chief (archiplasm) architype Cata- (cath-) or kata-; down, lower, under (catabolic) catastrophe Di-; twice, twofold (dimorphic) diameter (two radii) Dia-; through, across, apart (diameter, diagnosis) diameter Dicha-; in two, double (dichotomy) dichotomy Dys-; bad, difficult, hard, disordered (dysfunction) dysfunction Ek-, ex-; out form, outside (exophthalamus) eccentric Ekto-; without, on the outside (ectomere, ectopia) (see: ek-, ex-) En- (em-); in, within, among (endemic) energy Endo-; within (endothelium) endocrine Ento-; within (entotic: OT- “ear”) entropic (see: endo-)  Epi-; upon, on (epidermis) epidemic Eso-; inward, within (esotropic, esotoxin) esoteric Eu-; we, good, normal (eugenics) euphony Exo-; outside, outward, outer (exocolitis) exotic Hemi-; half, partly (hemialgia: ALGOS – “pain”) hemisphere Hyper-; above, over, excessive (hyperemic, hypertrophy) hyperactive Hypo-; low, under, below (hyponatremia)  hypocrite Meta-, (meth-); after, among, beyond, behind (metacarpal: KARPOS – “wrist”) metaphysical, metaphor, method Opistho-; behind (opithognathism)  optic Pali(n)-; back, again, once more (palikinesia: KINE – “movement”) palindrome  Para-; by the side of, near (paranoia: NOOS, “mind”) paranoia Peri-; around (periosteum) Periodontal (bone or tissue AROUND tooth) Pro-; before, in front of, forward (prophase) professional Pros-; to, in addition, near (prosencephalon: ENCEPHALON, brain) prosthetic Proso-, prostho-; forward, before, in front of (prosoplasia) prosthetic  My links: My patreon: ⁠https://www.patreon.com/user?u=103280827 My Ko-fi: https://ko-fi.com/rhetoricrevolution Send me a voice message!: https://podcasters.spotify.com/pod/show/liam-connerly TikTok: ⁠https://www.tiktok.com/@mrconnerly?is_from_webapp=1&sender_device=pc⁠ Email: ⁠rhetoricrevolution@gmail.com⁠ Instagram: https://www.instagram.com/connerlyliam/ Podcast | Latin in Layman's - A Rhetoric Revolution https://open.spotify.com/show/0EjiYFx1K4lwfykjf5jApM?si=b871da6367d74d92 Gut Guardian Discount Code: https://www.feelgoods.co/discount/LIAM64728

On Episode 27 of After the Breach podcast co-hosts Jeff and Sara share all about the most recent sightings from the Salish Sea. It has been a busy few weeks whale-wise and the duo felt they needed to catch up about it almost as soon as they had finished recording the previous episode! Dive in with them as they talk about the families that have been seen, a very quick sea lion hunt, and a new calf with one of their favorite families! If you are enjoying listening to our podcast, please share this with your friends, follow/subscribe, and leave us feedback/reviews! You can also find us on Instagram, Facebook and Youtube. Please send us feedback or questions at afterthebreachpodcast@gmail.com.   Links from this episode: The History of Cetacean Taxonomy and Nomenclature: https://youtu.be/ZAkUE60o2o8?si=l2xtliA02mM5HWOJ Photos from this episode: T19B breach. Photo by Jeff Friedman   T49As and T18s. Photo by Jeff Friedman   T63, "Chainsaw," with T65 and T65Bs. Photo by Jeff Friedman   T49A6, "Charlie II." Photo by Jeff Friedman        

Featuring: Michael "Boston" Hannon and Paul “Moonpir” Smith Running Time: 1:43:30 Music by MusiM: Homepage | Bandcamp Livestream Archive: YouTube This week on That Video Game Podcast (TVGP) we chat about SEGA Genesis / Mega Drive Classics, Lethal Company, Helldivers 2, Slice & Dice, Final Fantasy VII Rebirth, Stardew Valley, Unicorn Overlord. Become a patron of TVGP for just a few dollars a month at E1M1's Patreon Page! Get two month early access to Critical Misses, uncensored outtakes, and much more for just $5/month!

The Man of the West digs through the Nomenclature and the Letters to learn more about the name of everyone's favorite farmer.

In this episode, I talk about:* A step-by-step process for creating and naming defensive plays* Why it doesn't matter what you call things* Why you should create ‘buckets' or specific families before you name them* How to create signals for each of your calls* Building an inventory and why you should do it* I go through my simulated pressure, or QB ‘family,' of calls and their signals—» Articles on the above topics…WANT MORE ON THE PRESSURES? GET THE BOOK:A Complete Guide to the Hybrid 4-2-5—» For a comprehensive breakdown of how I teach & categorize my coverages, check out my full-length book on the topic, Match Quarters - A Modern Guidebook to Split-Field Coverages» DB 101 Playlist full of quick clinics on techniques, drills, & fundamentals.» Previous pod:» MatchQuarters is a reader-supported publication. So, make sure to subscribe, like, and share articles.© 2024 MatchQuarters | Cody Alexander | All rights reserved. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.matchquarters.com/subscribe

John Grimshaw has been interested in plants his entire life, as both gardener and botanist. He holds a first class degree in botany and a doctorate in the ecology of the forests of Mt Kilimanjaro from Oxford University. His Tanzanian connections remain important, and he's proud to be an honorary elder of the Maasai community of Lerang'wa, Tanzania. African plants remain an important botanical interest, but he is fascinated by all plants and has grown a huge diversity in his gardens. He has travelled widely to see plants growing in habitat. His first book was The Gardener's Atlas (1998), recounting the journeys plants have made from their source to our gardens. Working in The Netherlands for the seed company K. Sahin, Zaden. B.V., John was responsible for developing perennials and other plants for the seed trade. This gave him invaluable experience of commercial horticulture and management. Following that he joined Colesbourne Park in Gloucestershire as Gardens Manager, where he was responsible for maintaining and developing the historic Elwes family garden, especially the snowdrop collection. He co-authored the monograph Snowdrops (2002) with M Bishop & A Davis, published by Griffin Press. Between 2004-2009 he was lead author of a major book on trees introduced in the past 35 years, entitled New Trees, Recent Introductions to Cultivation, with co-author Ross Bayton. It was sponsored by the International Dendrology Society and was published by RBG Kew, in May 2009. In August 2012 he became Director of The Yorkshire Arboretum, North Yorkshire, with responsibility for the 120-acre arboretum and 20-acre Ray Wood, on the Castle Howard estate. This involves a wide range of management and administrative duties, fundraising and networking as well as active curation of the extensive collection. In 2021 the arboretum opened the country's first dedicated Tree Health Centre, to raise awareness of the problems facing trees from diseases, pests and climate change. He was appointed MBE for ‘services to tree health and plant conservation' in the 2024 New Year Honors List.   John is a member of the Royal Horticultural Society's Nomenclature and Taxonomy Advisory Group, the RHS Woody Plant and Gardens Committees, and in 2012 led the RHS review of the Award of Garden Merit. He speaks and writes widely on horticultural and tree-related subjects. Other interests include the arts, cookery and poultry-keeping. --- Send in a voice message: https://podcasters.spotify.com/pod/show/plantatrilliontrees/message Support this podcast: https://podcasters.spotify.com/pod/show/plantatrilliontrees/support

This episode features "Binomial Nomenclature and the Mother of Happiness" written by Alexandra Munck. Published in the January 2024 issue of Clarkesworld Magazine and read by Kate Baker. The text version of this story can be found at: https://clarkesworldmagazine.com/munck_01_24 Support us on Patreon at https://www.patreon.com/join/clarkesworld?

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medication Nomenclature⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Pharmacology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

This conversation focuses on the Delphi process for a new MASLD nomenclature. It starts with Jeff Lazarus describing what a Delphi process is and how it worked here. Jeff and two other key players in this process, Maru Rinella and Meena Bansal, describe what they consider some of its greatest strengths as well as one thing they wish had worked out better.Jeff's description focuses on the four rounds of data gathering and some key activities that transpired before the formal process began. He goes on to identify what he considers some of the pivotal outputs of this one. In particular, Jeff describes the focus on patients with alcohol and diet issues, and the naming of a new discreet disease for these patients (MetALD) as being “revolutionary.” Roger Green agrees with Jeff's assessment that the naming of MetALD was an important outcome and that the process had clear benefits in this way. He goes on to ask why people opted out of the process. Maru Rinella comments that some people opted out after the third phase due to disagreements with the direction of the activity. Roger refines the question to ask why people opted out in the first place. Jeff and Maru note the amount of work required for this kind of activity, and he, Maru Rinella and Meena Bansal all describe that not all invitees understood how important this process would be upon first invitation. Jeff and Maru go on to mention that the participation rate was high, somewhere around 80%.Roger asks what could have gone better. Maru, Jeff and Meena Bansal each note groups for which they wish participation had been broader, including possibly a broader representation of stakeholders (notably, more patients, although Maru notes this was not for lack of trying) and more organizations or countries.

This conversation shifts from the rearview to the path ahead. Louise Campbell starts by asking about the role of Allied Health Providers in the process. After this issue, process leaders Maru Rinella, Jeff Lazarus and Meena Bansal discuss how this will roll out as we move ahead.It starts with Louise Campbell asking why there Allied Health Providers did not play a larger role in the Delphi process. Maru Rinella replies that, in her vision, this group's involvement will be critical in the rollout and message development but less so in a Delphi process that was mostly about hashing out, as Maru puts it, “the nuances of the disease.” To Maru, this is also the place where patient voice brings the most pivotal value. Meena Bansal notes that there were some PAs and NPs in the Delphi process. Meena Bansal agrees that their role will be critical in discussions on how to communicate the disease to the patient (a topic we return to in later conversations). Louise appreciates, accepts and largely agrees with this discussion. Roger Green shifts focus from the past process to ask about the rollout phase: when it began, what it will include and when it might end. Meena says it will never end. Jeff Lazarus comments that while publication was the formal rollout, even before then groups were vying to be the first to change their names. He also noted that the article was published simultaneously in several journals with broad, rapid uptake in the literature. Since the key is to raise awareness and educate the population, he considers the speed and breadth of uptake a major sign of success. Maru Rinella comments that journal participation has been generally excellent.

This conversation ties up several issues related to MASH and the new MASLD nomenclature that the panel did not touch on earlier in the episode. These range from the impact the nomenclature might have on other elements of treatment to the impact of this effort over time. Finally, the panelists grade the process to date (they admit, their views might be a bit biased) and signs of success. Roger Green starts this conversation by asking what impact panelists believe the new MASLD nomenclature might have on NITs. From one perspective, Meena Bansal notes that it should have no impact given that NAFLD/NASH and MASLD/MASH map so similarly on top of one another. From a different perspective, Jeff Lazarus asks whether the nomenclature and accompanying guidelines from professional societies will result in more testing. The group aligns around the idea that patients living with Type 2 diabetes are an excellent target for increased testing with NITs given the high overlap of the two groups. Maru Rinella comments specifically that all efforts to tie T2DM to MASLD as frequently common metabolic diseases will be helpful and that discussing the proper use of NITs might be one way to make this connection. Louise Campbell agrees that increased focus on "Healthy Livers, Healthy Lives" will drive exactly these kinds of discussions. The rest of the episode consists of Roger asking panelists three questions, to which they respond: What might change over the next year or two? Meena believese that approval of a drug will drive significant growth in the learning curve and, with that, enhanced disease awareness and understanding. Jeff suggests that this will not take the form of a transition from NAFLD to MASLD, but instead that people first learning about the disease will use the new nomenclature properly. Mike Betel notes that on the Fatty Liver Alliance website, ~98% of searches are simply for "fatty liver disease." Over time, he anticipates this will change and also that websites like FLA will address "fatty liver" queries in terms of new nomenclature. Impact on ICD codes. Meena, who is doing significant work in this area, answers that the goal is to have no impact but simply a smooth cutover. How the group would grade its work on this activity to date. As Jeff notes, answers from the people who led the process are likely to be quite biased, but all gave fairly high grades. 

Our first conversation focusing on the new MASLD nomenclature surfaces as part of our coverage of the EASL Congress 2023. Hepatology researchers and key opinion leaders Sven Francque and Ian Rowe joined Jörn Schattenberg and Roger Green to discuss the value of the new nomenclature and its current and anticipated impact on their practices. This conversation focuses on the outcome of the nomenclature process, a three-stage Delphi process that produced new names and classifications for what had previously been known as fatty liver disease and henceforth will be known as steatotic liver disease (SLD). Sven, who was actively involved in the entire exercise, gives a concise summary of the process by which the new classifications were developed and how the new terminology will work. The rest of the conversation focuses on three issues.Excitement that we will now have the opportunity to study patients whose disease has both metabolic and alcohol-based components.The processes by which the three clinicians, Sven, Ian and Jörn are starting to share the new structure with their patients with varying degrees of success. One interesting observation emerges here from Sven: the English language terms do not translate equally into Dutch, so there is a patient advocate-led effort to create a new set of terms in Dutch.Roger raises concerns about implementation planning for the new nomenclature. One concern is around the possible impact on drug or diagnostic development and the other is about the kinds of communication issues covered in earlier episodes. Sven, who again worked more closely on the process, states with confidence that the change will not have an impact on drug or diagnostic trials. Subsequent events prove Sven right.

We're baaaack...! It's the start of Season Three here at the Podcast, and we're excited to once again be bringing you some weekly-ish discourse on Changeling: the Dreaming. As we proceed chronologically through the game's history, we're now in that wilderness between the end of 2nd edition and the launch of the 20th Anniversary edition. But that doesn't mean there's nothing to say about Changeling and it's place in the World of Darkness. We're talking today about Hunter: the Reckoning, Mummy: the Resurrection, and Demon: the Fallen, three WoD games that were concurrent with the sunset and slumber of the Dreaming. There's limited information with which to suss out how these three splats view and interact with the fae, but we never said we didn't like a challenge. If you're interested in purchasing any of the corebooks for those lines: Hunter: https://www.storytellersvault.com/product/639?affiliate_id=3063731 Mummy: https://www.storytellersvault.com/product/1251?affiliate_id=3063731 Demon: https://www.storytellersvault.com/product/636?affiliate_id=3063731 In the realm of shameless promotion, there's also the Bog Bodies book for Mummy "20th" that Pooka created here: https://www.storytellersvault.com/product/395251?affiliate_id=3063731, and if you'd like to hear Mage: the Podcast's dive into the 1st and 2nd edition Mummy books, check out https://magethepodcast.com/tomes-of-magick-a-world-of-darkness-mummy/ and https://magethepodcast.com/tomes-of-magick-mummy-second-edition/ respectively and respectfully. And of course, you can contact us through the following channels for all of your questions and musings on dank monstrosities and those who pursue them: Discord: https://discord.me/ctp Email: podcast@changelingthepodcast.com Facebook: https://www.facebook.com/profile.php?id=100082973960699 Mastodon: https://dice.camp/@ChangelingPod Patreon: https://www.patreon.com/changelingthepodcast YouTube: https://www.youtube.com/@ChangelingThePodcast your hosts Josh Hillerup (any pronoun) suggests that sysops are prime candidates for Imbuing. Pooka G (any pronoun/they) swoons for the linguistically superb Hekau of Nomenclature. "If the apocalypse comes— beep me." —Buffy Summers

This conversation focuses on the issues and visions that led to the identified need for a new MASLD nomenclature. Maru Rinella and Jeff Lazarus discuss the original goals of the process and how focus broadened and shifted throughout.It starts with Maru Rinella describing what she terms “an existential crisis” for the field around a publication suggesting changing the name of the disease from “non-alcoholic” fatty liver disease to “metabolic” fatty liver disease. She considers this the main impetus for key global players to converge. Jeff Lazarus notes that stigma and several other processes came into the discussion. Maru and Jeff agree that the participant recruitment process came in two phases, one where it was hard to get participants and a later point where it was to manage the size of the exercise. Jeff felt the tipping point happened when people understood how the Delphi process would work and also the need for this to succeed. Maru felt that people had to grasp the implications of a consensus process, which Delphi is. As the conversation ends, another leader in the process, Meena Bansal and a patient advocate participant, Mike Betel of the Fatty Liver Alliance, describe how they came to enroll.

The process of creating a new MASLD nomenclature for the condition formerly known as Fatty Liver Disease was a multi-year process with unique challenges and complications. Three leaders in the process, Maru Rinella, Jeff Lazarus and Meena Bansal, and patient advocate Mike Betel join Louise Campbell and Roger Green to discuss the process, transition and rollout.00:00:00 - Surf's Up: Season 5 Episode 3Co-hosts Louise Campbell and Roger Green sit with Maru Rinella, who co-chaired the New Nomenclature process, Jeff Lazarus, who oversaw the entire Delphi process, Meena Bansal, who played a key role and co-moderated the 2023 AASLD session, and patient advocate Mike Betel to discuss the entire process from inception to today and beyond.00:03:57 - Meet Meena BansalDr. Meena Bansal, Division Chief at Mt. Sinai Hospital in New York, discusses how she became involved in liver disease and her current research interests, and shares one fact about herself that might surprise you. 00:05:47 - GroundbreakerPanelists share one piece of good personal or professional news from the previous week.00:08:22 - Characterizing the Nomenclature ProcessMaru and Jeff discuss the original goals of the process and how focus broadened and shifted throughout.00:16:02 - How the Delphi Process WorkedJeff describes the overall process. Roger asks about people who chose not to participate at the outset, which leads to a discussion about the overall rate of participation. Roger then asks what might have worked better, which leads Maru, Meena and Jeff to discuss groups they wish had been better represented. 00:27:05 - The Role of Allied Health ProvidersLouise asks why Allied Health Providers did not play a larger role throughout the process. Maru and Meena differentiate between providers' roles in the early process and the mechanics of rolling out to the patient community.00:29:38 - Focusing on the RolloutRoger's question about the rollout leads Jeff to focus on some of the key early stage events. Jeff and Maru go on to discuss the high level of participation from key journals.00:33:32 - Early AwarenessMike Betel brings a piece of data on physician awareness from the pre-test of a study he is conducting in Canada, which serves as a conduit into the entire topic of who is aware of the nomenclature today and how knowledge will spread over time. 00:38:56 - The New Message for Patients Louise notes that the upcoming UK effort to bring VCTE screening to primary care will provide an effort to define and characterize the disease for patients. Meena comments that providers have done this informally for years, but while the message used to be that the patient "just has fat on the liver," this nomenclature will formalize the disease, remove "just," and focus the patient on therapy.00:39:15 - MetALD - A New Disease in the SLD FamilyRoger states that in his mind, the newly defined disease MetALD is a major positive outcome of the process. Maru, Meena and Louise each describe ways this new definition will aid diagnosis and treatment, Mike notes that the message still must be tailored for each patient. 00:43:55 - Implication for Diagnostics The group discusses the idea that while the nomenclature will not lead to new diagnostic tests, it might lead to increased and more appropriate use of the tests that exist.00:48:25 - The Future of the NomenclatureRoger asks the group where this process will be in a year and five years. Answers vary.00:51:58 - Grading the Process So FarRoger asks panelists how they grade the process to date. Grades are high although, as Jeff notes, they are grading their own work.00:55:27 - Business ReportNews on audience metrics, the upcoming Question of the Week, next week's epidemiology discussion and this week's Vault conversation

Surfing the MASH Tsunami continues its 2023 wrap-up conversations with Global Liver Institute Vice President of Liver Health Programs Jeff McIntyre, along with co-hosts Louise Campbell and Roger Green. The conversation focuses on Jeff's mixed assessment of 2023, focusing largely on drug approvals and the new nomenclature.  In 2023, the field of fatty liver disease experienced both setbacks and progress, encapsulated in Jeff's phrase, "Two steps back, one step forward." Central issues included drug approval processes, nomenclature changes, and advancements in understanding and treating Non-Alcoholic Steatohepatitis (NASH). The year was marked by significant efforts to address fatty liver disease, but results were mixed, partly due to the complexities and inefficiencies in the drug approval process.A notable moment was the FDA Advisory Committee's review of obeticholic acid, which highlighted issues with the clarity and reliability of the FDA's drug approval endpoints. This process was perceived as bureaucratic, sometimes disheartening, and not always effectively engaging with patient communities. Jeff underscores the importance of enhancing communication between various stakeholders in healthcare, including medical societies, patient communities, and regulatory bodies.The conversation also reveals a consensus on the need for more involvement of patients and nurses in decision-making processes. Jeff stresses the necessity of educating the FDA about liver disease and the impact of drug approvals on patient safety, advocating for a stronger voice for patients and nurses in redefining the FDA's approach to safety.Roger adds to the discussion by expressing concerns about institutional risk aversion in regulatory processes, which can impede drug approvals. He points out that some FDA committee members lack basic knowledge about fatty liver disease, leading to naive questions and decisions. Louise highlights the reclassification of fatty liver disease as metabolic dysfunction and its potential benefits, suggesting that integrating liver disease treatment within endocrine and cardiology care could be beneficial due to the interconnected nature of these fields.Looking ahead to 2024, Jeff anticipates positive developments in drug approvals and increased patient involvement. He notes the change from International NASH Day to Global Fatty Liver Day, indicating a shift in nomenclature and expectations of more patient engagement in regulatory discussions and decision-making processes.In conclusion, the conversation reflects a blend of optimism and caution regarding the future of fatty liver disease treatment. The importance of patient-centered approaches and collaborative efforts among healthcare stakeholders is emphasized, highlighting the ongoing need for patient advocacy organizations to play a significant role in navigating the complexities of the disease. This includes dealing with the challenges posed by the new nomenclature and the potential for new treatments. The dialogue underscores the necessity for a more integrated, patient-focused healthcare system that prioritizes the perspectives and needs of those directly affected by fatty liver disease.

What's in a name? That which we call iPACK by any other name would...well, actually, we're not sure. In this controversial episode Amit and Jeff debate (and disagree!) about proper naming conventions, the value of eponyms, and who has the right to name blocks. Stay tuned for CAPS, PECS, RAPTIR, SPANK, and more...

How do we address the devastating intersection of legitimate war and human rights catastrophe? Yehuda Kurtzer is joined by Yehudah Mirsky, professor, author, and former special advisor to the US State Department Human Rights Bureau, for a master class on the trajectory, impact, and underlying values of the human rights discourse. They explore what shapes our understanding and assumptions of human rights and where liberal, universalist ideals overlap with Zionism, Jewishness, and Jewish values on the world stage today.      Mentioned in this episode:     Hannah Arendt: The Rights of Man, the Political Community, Judgment and Recognition | SpringerLink By Hannah Arendt   Human rights died in Gaza - UnHerd  by Yehudah Mirsky    Believe Israeli Women - Identity/Crisis | Podcast on Spotify    #51: Genocide, Antisemitism, and the Nomenclature of Hatred - Identity/Crisis | Podcast on Spotify     (PDF) The Last Utopia: Human Rights in History by Samuel Moyn (researchgate.net)    (PDF) Durkheim's 'Individualism and the Intellectuals | steven lukes - Academia.edu     Why Hamas Killers Invoked God's Name, Not the Liberation of Palestine - Israel News - Haaretz.com by Anshel Pfeffer (behind a paywall)    JOIN OUR EMAIL LIST FOR MORE HARTMAN IDEAS  

'Sound and Nomenclature' What is a wine blend?   What's the difference between a varietal vs a variety?   And what is a Maquette…or is it a Marquette?   This short 'small bite' episode will answer these questions about wine, words...and sounds.

The Unseen World Of SeaweedsChances are you don't give much thought to seaweed unless you're at the beach, or perhaps when you're considering a dinner menu. But the thousands of seaweed species around the world are a key part of our coastal ecosystems.Seaweeds photosynthesize, provide food and shelter for marine animals, stabilize the coastlines, and even contribute to making your ice cream creamier (through an ingredient called carrageenans, extracted from red seaweeds in the Rhodophyceae family). Increasingly, they're also being investigated as a source of biofuels and as biological factories, due to their fast-growing nature.Dr. John Bothwell, a phycologist at Durham University in the UK, has written a book in praise of seaweeds. In Seaweeds of the World: A Guide To Every Order, he highlights beautiful, unusual, and important species from each of the three seaweed lineages—green, red, and brown. In this segment, he talks with SciFri's Charles Bergquist about some of his favorite species, where the seaweeds fit into the web of life, and the importance of seaweeds to the global ecosystem.“Dark Fungi” Species Don't Get Names. Should They?Scientists have collected DNA samples of thousands of new fungus species over the past several decades. These fragments of fungal DNA are found nearly everywhere—in soil, decomposing logs, water, and even in the air. Mycologists have enough data to place these new species within the fungal family tree, but haven't collected physical samples of them or been able to grow them in a lab. This means that according to the International Code of Nomenclature for algae, fungi, and plants, these new species cannot receive scientific names.How can you understand a fungus that has no name? SciFri producer Shoshannah Buxbaum talks with fungal taxonomist Dr. David Hibbett, professor of biology at Clark University, about a proposal to give these “dark fungi” scientific names, and why naming living things might help us better protect the Earth's biodiversity.Transcripts for each segment will be available the week after the show airs on sciencefriday.com. To stay updated on all things science, sign up for Science Friday's newsletters.

In this replay episode from 5 years ago in 2018, we enter into the world of cardiac morphology and speak with Professor Leo Lopez of Stanford University about a recent work he wrote with the International Society for Nomenclature of Pediatric and Congenital Heart Disease regarding proper nomenclature for VSD's. Is it defect geography or borders that are most important in naming these structures? How was agreement forged between such disparate super-hero experts in cardiovascular medicine and congenital heart disease? Is Dr. Lopez using these designations at the present time? What's next for the nomenclature group? Dr. Lopez shares his insights this week.As a special treat, Dr. Lopez also sings as the musical coda to today's program. A very special treat indeed and certainly worth replaying! Hoping that all enjoy! doi: 10.1016/j.athoracsur.2018.06.020

Surfing the MASH Tsunami continues its 2023 wrap-up conversations with patients and patient advocates Mike Betel of the Fatty Liver Alliance (Canada) and Tony Villiotti of NASH kNOWledge (Pittsburgh, PA), along with co-hosts Jörn Schattenberg and Roger Green. The conversation focuses on viewing the year's major events and upcoming priorities from a patient advocate's point of view. The conversation starts by looking at the roles that patient advocates in different countries have played in the global mix. The conversation starts by focusing on highlights and not-so-highlights of the year, with the first group including the return of face-to-face conferences with active patient involvement and education, the second group including the complete response letter for obeticholic acid and the new nomenclature seen as generally positive but somewhere in the middle.The conversation's first deep dive comes around the new nomenclature. Mike notes that this was an important initiative for every stakeholder in the MASLD/NAFLD community during the year. Tony describes himself as originally having been opposed because of all the re-work it will require for his organization and also because at a 1:1 level, it becomes hard to envision a physician explaining this disease to patients without raising the concept of "fat." They start by discussing liquid tests, but Mike then shifts to VCTE and the idea that Canadian patients wait six months for VCTE, which is not tenable in the long-run. Mike discusses having gone to the Canadian parliament this past spring and that he learned how little members know about MASLD. He sees increased meetings and conversations, particularly with patients telling their own stories, as critical to building government support. In response to a question from Roger, both Tony and Mike consider the new nomenclature background noise that will not meaningfully affect how patients and their providers communicate. Jörn notes that in German, he cannot discuss metabolic disease or steatosis because they will mean nothing to the patient, so he uses the term "fat liver," which is the literal German translation. The conversation shifts to the concept of "stigma", with Jórn starting by noting that the phrase "fat liver" has little stigma. Tony and Jörn agree that framing the issue properly can overcome any perceived stigma on the part of patients. The group agrees that it will take time for stakeholders to adopt the nomenclature, but, as Mike says, "it's here" and everyone will need to get used to it. In response to a question from Roger, both Mike and Tony highlight increased use of and access to non-invasive testing (NITs) as a primary advocate goal for 2024.  They also discuss gaining access to VCTE on a timely basis. Roger asks what listeners should consider about working more effectively with patient advocate groups. Mike starts by asking that manufacturers and sponsors bring patients into the clinical trial design process far earlier. He also notes that patient advocate groups need financial support from all sources including manufacturers, to support education. Tony mentions the importance of working with children, going into schools to educate children, and, through them, to reach the parents. Advocates' hopes for 2024 start with the idea of resmetirom being approved. Mike looks to learn more about what primary care physicians in Canada are doing now and how he can motivate them to do more. Mike and Roger discuss strategies for working with industry.  Tony mentions the importance of motivating patients to seek their own care. The last comments are around the availability of multi-lingual materials in the two countries. 

Surfing the MASH Tsunami kicks off its 2023 wrap-up conversations with Jeff Lazarus, the 2023 winner of the Distinguished Scientific Achievement Award from the American Liver Foundation. He discusses three core MASLD-related opportunities for which he played a key role in 2023: the Research in Action initiative, the new MASLD nomenclature process and the Healthy Livers, Healthy Lives coalition.Most of this discussion focuses on Jeff's work leading the Research in Action coalition. As Jeff notes, this was the first time the MASLD "field has set its own agenda." Absent governmental or not-for-profit agencies driving the discussion, a group that has grown to over 400 collaborators published its own action agenda in AASLD and EASL publications. Jeff discusses the process through which he built this consensus, focusing on domains identified in earlier meetings: (i) treatment and care; (ii) models of care; (lll) increased awareness; and (iv) leadership. Jeff feels the legitimacy of this activity comes from "casting the net wide" with a series of Wilton Park meetings and from demonstrating how far MASLD lagged behind other non-communicable diseases in terms of goal development, structured support and public presence. Another key element in the initiative's success was a side event at the World Health Assembly led by the four major hepatology organizations, including not only AASLD and EASL but also APASL, and ALEH. Efforts to create parity with other non-communicable diseases will result in increased funding and "massive" increases in awareness.Today, the other NCDs mention other related metabolic diseases but not MASLD or MASH. Another example of the lack of urgency around MASLD: NIH just put out a call for funding for HIV, which Jeff notes might not be as high a priority in 2024 as MASLD.At this point, Jörn Schattenberg joins the conversation to congratulate Jeff on his recognition and award and also to discuss how important it is to the entire community that Jeff plays the role he does. In response, Jeff comments that one benefit of the Award is that it ratifies the importance of the kinds of consensus building and application of public health initiatives in MASLD space.From here, Jeff and Jörn step further forward to discuss the importance of funding prevention and education programs, done by governments in the EU and perhaps public or private players in the US. Jörn discusses the multidisciplinary nature of the Barcelona meeting they co-chair and how it provides outreach beyond hepatology. Jeff continues the thought to discuss the importance of social determinants of health (for example, food insecurity) in a world where healthy foods cost far more than more common alternatives (basmati rice costs 3x basic white rice).Roger asks how the new nomenclature is proceeding. Jeff says it is doing quite well in that there is significant global buy-in. Major centers around the world are adopting the new nomenclature for their meetings and clinics, but, Jeff notes, it is difficult for physicians to explain the disease to patients without using the words "fat" or "fatty."As the conversation winds up, Jeff notes the importance of bringing primary care to the education and outreach processes and the goal of doubling the number of patients screened over the next four years. The conversation closes on this note: much that must be done, but confidence that the energy to achieve these big goals is coalescing properly.

We're in denial that winter is coming, so we're turning up the heat with some of the best new music from:Austin Kiefer, Benito, CeCe X, DexOflex, Gretchin, Heff Vansaint, Hermosa, Johanna Warren, Kim Chuah, Nomenclature, SH!NER, SNG, STORRY, and Vampire Campfire. ⚡️CONNECT WITH THE Q⚡️ Website: ⁠⁠⁠⁠https://www.curatedbyq.com⁠⁠⁠⁠ ⚡️FB/Instagram/Twitter @theqreviews ⚡️YouTube.com/@QCreativeNetwork⚡️Apparel Shop https://qreview.threadless.com ⚡️Theme Music provided and performed by UK DJ and producer Hectic @hectictracks on Instagram⚡️

Understand the vocabulary of cholesterol so that we are all on the same page and having the same conversation. What's the difference between LDL cholesterol versus LDL particles versus apolipoprotein B (ApoB)? LDL-C, LDL-P, ApoB, Lp(a) https://dralo.net/links

Mark and Michael sit down for a an old school rant that begins with Michael asking the very serious question, "Did government, Illuminati, secret society light up Burning Man with ebola so that they could off all of the people who might be able to make psychedelics legal?"Clearly, this is a very serious conversation, wherein we discuss camping, capitalism, bartering and freedom (as it relates to the presence and function of the tent city that pops up in front of the NonProphet Event Center with some regularity), accepting or abdicating responsibility, and the influence of drugs on self-appreciation and value. Michael describes the remarkable difference between 'associative' vs. disassociative behavior and that perhaps, in order to steer oneself towards better life experiences, towards a 'higher plane' so to speak, one must actively associate with reality instead of evading it, and open oneself to feeling and sensing and being aware, and that may begin with a basic premise of making different decisions regarding the food one consumes. Change on the most fundamental, dare I ay mundane, level can influence an entire cascade of different outcomes.In the moment of fulfillment, after a good and healthy meal that doesn't make you feel like shit, shared with a loved one, people feel satisfied, but society — as it is set up here — can't handle folks who are satisfied because they aren't seeking and they're not consuming and they're not indulging ... they are appreciating where they are, in the moment. That's a good thing for the species but not necessarily for the frenzied socio-economic system we find ourselves within ... because whosoever is satisfied won't fall for the advertising.And then we turned the focus to business and marketing and Michael helped me realize that continual growth of cells in the body is cancer but continual growth in business is expected and if it doesn't happen the business is considered a failure. Or at minimum unsuccessful.So how do businesses keep growing, keep increasing market share and brand awareness? Which leads to us addressing social engineering as a mechanism to turn profit on the back of predictable human behavior ... ugh, the manipulation is at an all time high while the resources, the open-to-buy of the potential customers, is rapidly declining. That said, money changes everything, and those who have it don't have to spend time or energy getting what they believe they want; they can change the outcome without actually changing their behavior. And that is very seductive ... but also a dead end.Finally, when it comes to marketing for NonProphet, we agree that we should be careful about putting the business name and logo on such cheap shit as might quickly end up in a landfill ... is that how we want to be remembered in the present and in the future? Yeah, picking through useless NonProphet tchotchkes at the dump ... that sounds good. So go ahead, acquire stuff, let it weigh you down, because carrying weight is good training, and this podcast is about fitness.

In this episode, we review the high-yield topic of ⁠Tumor Nomenclature ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Oncology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

Anatomy: Scientific Definition: The study of the structure and organization of living organisms. Etymology: From Greek "anatome" (ana - up, tome - cutting), referring to the dissection or cutting up of organisms for study. Physiology: Scientific Definition: The study of how living organisms function and the mechanisms that drive their bodily processes. Etymology: From Greek "physis" (nature) and "logia" (study), meaning the study of nature. Kinesiology: Scientific Definition: The study of human movement, including the mechanics, muscular function, and coordination involved in movement. Etymology: From Greek "kinesis" (movement) and "logia" (study), meaning the study of movement. Biomechanics: Scientific Definition: The study of mechanical principles applied to living organisms and their movement. Etymology: From Greek "bios" (life) and "mēkhanē" (machine), meaning the study of the mechanical aspects of life. Muscle Contraction: Scientific Definition: The process by which muscle fibers generate force and shorten in length. Etymology: "Muscle" comes from Latin "musculus" (little mouse) due to the visual similarity of muscles under the skin to moving mice. Isometric Exercise: Scientific Definition: Muscle contraction without a change in muscle length or joint angle. Etymology: "Iso" from Greek (equal) + "metric" from Greek "metron" (measure), meaning equal measurement. Isotonic Exercise: Scientific Definition: Muscle contraction with a change in muscle length and constant tension. Etymology: "Iso" (equal) + "tonic" from Greek "tonos" (tension), meaning equal tension. Hypertrophy: Scientific Definition: The enlargement of muscle fibers due to increased protein synthesis. Etymology: From Greek "hyper" (over) + "trophia" (nourishment), meaning excessive nourishment. Atrophy: Scientific Definition: The wasting away or reduction in size of muscle tissue due to disuse or disease. Etymology: From Greek "a" (without) + "trophe" (nourishment), meaning without nourishment. Aerobic Exercise: Scientific Definition: Physical activity that requires oxygen for energy production over an extended period. Etymology: "Aero" from Greek "aēr" (air) + "bios" (life), meaning life with air. Anaerobic Exercise: Scientific Definition: Physical activity that does not heavily rely on oxygen for energy production. Etymology: "Ana" from Greek "an" (without) + "aēr" (air), meaning without air. Cardiovascular System: Scientific Definition: The system responsible for circulating blood throughout the body, including the heart and blood vessels. Etymology: "Cardio" from Greek "kardia" (heart) + "vascular" from Latin "vasculum" (small vessel), meaning heart and vessels. Skeletal Muscle: Scientific Definition: Muscles attached to bones that allow for movement through contraction. Etymology: "Skeletal" from Latin "sceletus" (skeleton) + "muscle" as mentioned earlier. Flexion: Scientific Definition: Decreasing the angle between two body parts. Etymology: From Latin "flectere" (to bend). Extension: Scientific Definition: Increasing the angle between two body parts. Etymology: From Latin "extendere" (to stretch out). Agonist: Scientific Definition: The muscle primarily responsible for a specific movement. Etymology: From Greek "agonistes" (combatant), referring to someone competing in a contest. Antagonist: Scientific Definition: The muscle that opposes the action of the agonist. Etymology: From Greek "antagonistes" (opponent), referring to someone opposing in a contest. Proprioception: Scientific Definition: The sense of the position and movement of the body. Etymology: "Proprio" from Latin "proprius" (one's own) + "ception" from Latin "capere" (to take), meaning taking hold of one's own. --- Support this podcast: https://podcasters.spotify.com/pod/show/liam-connerly/support

2:00 - Doug's black AI radio DJ 7:00 - Anthony is an asshole at work 13:00 - The titanic submarine 22:00 - Doug is a history buff 29:00 - Death by bagel 43:00 - Do not make jokes about my dead dog 1:00:00 - Doug knows about grenades 1:11:00 - Superchats & Phonecalls   Buy our coffee - https://arizonabaycoffee.com/   Wanna contribute to these show notes or notes from past shows? - https://forms.gle/ZekwDjQoJGRxnCw8A If you want to support the show and get weekly bonus episodes as well as the full Dear Flabby recordings, "The Bracket Show", "Hamilton & Piccolo", "Conspiracies with Drake" and more - head over to https://www.patreon.com/WhosRight. We also have all of our bonus episodes (200+) over at https://whosright.supercast.tech/ Link Tree - https://linktr.ee/whosrightpocast Join this channel to get access to perks: https://www.youtube.com/channel/UCG-4t7txcrxM35J6VXaHdZA/join Subscribe to our newsletter "The immaculate conception of the order of Dougalos" - https://whosright.substack.com Want to contribute to our newsletter? Submit by sending it to Submissions@whosrightpodcast.com Dear Flabby podcast feed - https://open.spotify.com/show/5tsoFqEunoBkGTcdFDlajJ?si=eGUFoowhROeymFhfzk-2eA&utm_source=copy-link Watch the show live on Youtube - https://www.youtube.com/WhosRightPodcast?sub_confirmation=1 You can find our merch, our PO box, links to submit Dear Flabby questions, and everything else over at https://whosrightpodcast.com/

Tony Stewart was about to run his first Indy 500. It should have been the best day of his life.. but he was the only star who showed up. That fateful day is now known in racing lore as part of “The Split.” But how did open-wheel racing get to that point? What exactly is the difference between CART and IndyCar and Champ Car and all the other names we call this sport? And why does it always seem to be in turmoil? Today on Past Gas, it's a brief history of the many dramatic twists and turns in the world of IndyCar. More about Show: Follow Nolan on IG and Twitter @nolanjsykes.   Follow Joe on IG and Twitter @joegweber. Follow Donut @donutmedia, and subscribe to our Youtube and Facebook channels!   Don't forget to subscribe to the podcast for free wherever you're listening or using this link: http://bit.ly/PastGas. If you like the show, telling a friend about it would be helpful! You can text, email, Tweet, or send this link to a friend: http://bit.ly/PastGas. Thanks to our sponsors: Get Valvoline for your car! Sign up today at butcherbox.com/GAS and use code BONUS100 to get 1 pack of free bacon in EVERY box for the life of your membership PLUS $100 off your first order.  Start cancelling your unused subscriptions and save money at RocketMoney.com/gas Download the FREE Upside App and use promo code pastgas to get $5 or more cash back on your first purchase of $10 or more.  Learn more about your ad choices. Visit podcastchoices.com/adchoices